NPSP

NPS Pharmaceuticals and Takeda Revise Agreements and NPS Re-Gains Full Worldwide Rights to Teduglutide and Recombinant Human Parathyroid Hormone 1-84

[Business Wire] – BEDMINSTER, N.J. & OSAKA, Japan–(BUSINESSWIRE)– NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and Takeda Pharmaceutical Company Limited (TSE: 4502, “Takeda”) announced today that NPS has re-gained the full … moreView todays social media effects on NPSPView the latest stocks trending across Twitter. Click to view dashboardSee who NPS is hiring next, click here to view […]

PropThink: NPSP Preparing for PDUFA and Commercialization with Gattex Recommendation in the Bag

[ACN Newswire] – By Jake KingOn Tuesday, Gattex (teduglutide) received a unanimous recommendation for approval from the FDA’s Gastrointestinal Drugs Advisory Committee, suggesting that the FDA may officially approve the … moreView todays social media effects on NPSPView the latest stocks trending across Twitter. Click to view dashboard […]